DeFloria, Inc.
PrivateLast Round
Debt
Jul 15, 2025
Est. Valuation
$50M
Total Funding Raised
$7.75M
Company Overview
DeFloria, Inc. is a biotechnology company developing AJA001, an oral solution made from full-spectrum hemp extract to treat irritability associated with autism spectrum disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B2C
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeFloria, Inc. Comparables
Compare DeFloria, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kingdom Therapeutics | 81% | |
| Neurotech International Ltd | 78% | |
| Zelira Therapeutics Ltd | 77% |
DeFloria, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 15, 2025 | ||||
| Joint Venture | Apr 6, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 140% MoM.
DeFloria, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DeFloria, Inc.'s valuation, stock price, and market status.
Is DeFloria, Inc. a public or private company?
DeFloria, Inc. is a private company.
What is the current stock price of DeFloria, Inc.?
DeFloria, Inc. is a private company, so its shares have no public market price. Caplight tracks DeFloria, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DeFloria, Inc. worth (valuation)?
DeFloria, Inc.'s valuation is estimated at $50.0M based on funding round data.
Can I buy DeFloria, Inc. stock?
DeFloria, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DeFloria, Inc.'s last funding round?
DeFloria, Inc.'s most recent funding round was Debt on July 15, 2025.
Who are the main investors in DeFloria, Inc.?
Investor information for DeFloria, Inc. is not publicly disclosed.
Will DeFloria, Inc. IPO soon?
No public IPO plans have been announced for DeFloria, Inc..
How can I track DeFloria, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in DeFloria, Inc.'s shares on secondary markets.